STOCK TITAN

[144] Zai Lab Limited American SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Zai Lab Limited (ZLAB) Form 144 notice shows a proposed sale of 610 American Depositary Shares (ADS) with an aggregate market value of $21,512.75 to be sold on 08/15/2025 via Fidelity Brokerage Services on NASDAQ. The ADS were acquired on 08/14/2025 through restricted stock vesting and were paid as compensation. The filing also discloses three prior sales by Yajing Chen during the past three months totaling 16,389 ADS for gross proceeds of $524,496.72. The filer certifies no undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider sale notice; small scheduled sale relative to total outstanding ADS, prior insider sales reported.

The Form 144 is a standard disclosure for an insider proposing to sell securities under Rule 144. It documents the acquisition source as restricted stock vesting and classifies the payment as compensation. The notice lists the broker, proposed sale date, and aggregate market value, meeting regulatory transparency requirements. Prior dispositions by the named individual are enumerated, showing cumulative recent sales of 16,389 ADS for $524,496.72, which may be relevant for investor sentiment but do not by themselves indicate company-level financial change.

TL;DR: Compliance-focused filing documenting insider vesting and planned sale; disclosure is complete for Rule 144 purposes.

The filing explicitly ties the shares to restricted stock vesting, which clarifies the origin of the securities and supports Rule 144 eligibility. The signer affirms no undisclosed material adverse information, aligning with required certifications. This document is governance-positive in that it provides clear audit trail and broker details; it contains no new operational or financial information about the issuer itself.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

2.17B
106.96M
1.74%
42.53%
4.26%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI